130 related articles for article (PubMed ID: 9434957)
1. Pten, a candidate tumor suppressor gene, maps to mouse chromosome 19.
Hansen GM; Justice MJ
Mamm Genome; 1998 Jan; 9(1):88-90. PubMed ID: 9434957
[No Abstract] [Full Text] [Related]
2. A study of the PTEN/MMAC1 gene in 136 breast cancer families.
Chen J; Lindblom P; Lindblom A
Hum Genet; 1998 Jan; 102(1):124-5. PubMed ID: 9490290
[No Abstract] [Full Text] [Related]
3. [Involvement of protein tyrosine phosphatases in cancer development].
Hinoda Y; Idogawa M; Imai K
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1186-92. PubMed ID: 9655978
[No Abstract] [Full Text] [Related]
4. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
5. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
Li DM; Sun H
Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
Marsh DJ; Dahia PL; Zheng Z; Liaw D; Parsons R; Gorlin RJ; Eng C
Nat Genet; 1997 Aug; 16(4):333-4. PubMed ID: 9241266
[No Abstract] [Full Text] [Related]
7. Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene.
Whang YE; Wu X; Sawyers CL
J Natl Cancer Inst; 1998 Jun; 90(11):859-61. PubMed ID: 9625175
[No Abstract] [Full Text] [Related]
8. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression.
Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK
Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA
Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567
[TBL] [Abstract][Full Text] [Related]
10. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
Wang SI; Parsons R; Ittmann M
Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551
[TBL] [Abstract][Full Text] [Related]
11. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
[TBL] [Abstract][Full Text] [Related]
12. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang SI; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner SH; Giovanella BC; Ittmann M; Tycko B; Hibshoosh H; Wigler MH; Parsons R
Science; 1997 Mar; 275(5308):1943-7. PubMed ID: 9072974
[TBL] [Abstract][Full Text] [Related]
13. Phosphatases and tumorigenesis.
Parsons R
Curr Opin Oncol; 1998 Jan; 10(1):88-91. PubMed ID: 9466490
[TBL] [Abstract][Full Text] [Related]
14. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
[TBL] [Abstract][Full Text] [Related]
15. PTEN: sometimes taking it off can be better than putting it on.
Myers MP; Tonks NK
Am J Hum Genet; 1997 Dec; 61(6):1234-8. PubMed ID: 9399917
[No Abstract] [Full Text] [Related]
16. PTEN and inherited hamartoma-cancer syndromes.
Eng C; Peacocke M
Nat Genet; 1998 Jul; 19(3):223. PubMed ID: 9662392
[No Abstract] [Full Text] [Related]
17. Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.
Maxwell GL; Risinger JI; Tong B; Shaw H; Barrett JC; Berchuck A; Futreal PA
Gynecol Oncol; 1998 Jul; 70(1):13-6. PubMed ID: 9698466
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Cowden syndrome: through the looking glass of oncology.
Eng C
Int J Oncol; 1998 Mar; 12(3):701-10. PubMed ID: 9472113
[TBL] [Abstract][Full Text] [Related]
19. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.
Arch EM; Goodman BK; Van Wesep RA; Liaw D; Clarke K; Parsons R; McKusick VA; Geraghty MT
Am J Med Genet; 1997 Sep; 71(4):489-93. PubMed ID: 9286463
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
